$RXO stock has now risen 14% today, according to our price data from Polygon. There has been approximately $43,716,765 of trading volume.
Here is what we see in our data on $RXO (you can track the company live on Quiver's $RXO stock page):$RXO Insider Trading Activity
$RXO insiders have traded $RXO stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $RXO stock by insiders over the last 6 months:
- THOMAS A SZLOSEK has made 2 purchases buying 16,200 shares for an estimated $250,228 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RXO Hedge Fund Activity
We have seen 146 institutional investors add shares of $RXO stock to their portfolio, and 152 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. removed 2,730,665 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $42,926,053
- HOOD RIVER CAPITAL MANAGEMENT LLC removed 1,315,519 shares (-66.9%) from their portfolio in Q2 2025, for an estimated $20,679,958
- FRANKLIN RESOURCES INC removed 1,155,234 shares (-48.7%) from their portfolio in Q2 2025, for an estimated $18,160,278
- ORBIS ALLAN GRAY LTD added 1,142,710 shares (+3.8%) to their portfolio in Q2 2025, for an estimated $17,963,401
- FRED ALGER MANAGEMENT, LLC removed 1,100,145 shares (-52.3%) from their portfolio in Q2 2025, for an estimated $17,294,279
- MACQUARIE GROUP LTD removed 974,894 shares (-80.5%) from their portfolio in Q2 2025, for an estimated $15,325,333
- VICTORY CAPITAL MANAGEMENT INC removed 955,302 shares (-97.2%) from their portfolio in Q2 2025, for an estimated $15,017,347
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$RXO Analyst Ratings
Wall Street analysts have issued reports on $RXO in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 08/12/2025
- Truist Securities issued a "Buy" rating on 04/24/2025
- Jefferies issued a "Buy" rating on 04/11/2025
- Susquehanna issued a "Negative" rating on 03/26/2025
To track analyst ratings and price targets for $RXO, check out Quiver Quantitative's $RXO forecast page.
$RXO Price Targets
Multiple analysts have issued price targets for $RXO recently. We have seen 12 analysts offer price targets for $RXO in the last 6 months, with a median target of $17.5.
Here are some recent targets:
- Brandon Oglenski from Barclays set a target price of $17.0 on 08/12/2025
- Thomas Wadewitz from UBS set a target price of $15.0 on 08/08/2025
- Brian Ossenbeck from JP Morgan set a target price of $14.0 on 07/08/2025
- Ravi Shanker from Morgan Stanley set a target price of $21.0 on 07/07/2025
- Ariel Rosa from Citigroup set a target price of $18.0 on 05/21/2025
- Ken Hoexter from B of A Securities set a target price of $18.0 on 05/16/2025
- Christian Wetherbee from Wells Fargo set a target price of $15.0 on 05/08/2025
You can track data on $RXO on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
